GlassScriptPhysician profile
Stephen M Swirsky
NPI 1003864638
$7,087.07
in general payments reported to CMS, 2019-2025
8 companies · $2,001 in 2025
The $2,001 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,709 · 2020: $1,755 · 2021: $28.12 · 2022: $1,242 · 2023: $305 · 2024: $46.55 · 2025: $2,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421 · Travel and Lodging: $931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,421.36 |
| Travel and Lodging | $931.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Edge Orthopaedics, INC. | $3,005.63 | 2019-2025 | |
| Miach Orthopaedics, INC. | $1,811.58 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $1,053.92 | 2021-2024 | Tricera Handpiece |
| Arthrex, INC. | $889.45 | 2020 | |
| Smith+Nephew, INC. | $171.41 | 2020 | |
| Vericel Corporation | $74.50 | 2025 | Maci |
| Djo, LLC | $42.75 | 2025 | Cmf |
| Kowa Pharmaceuticals America, INC. | $37.83 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Swirsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.